Case report demonstrates 18F-FDG PET/CT reveals recurrence in medullary thyroid carcinoma, indicating this imaging's importance when conventional imaging is negative.
Medullary thyroid carcinoma (MTC) is a rare neuroendocrine tumor with variable clinical presentation, posing both diagnostic and therapeutic challenges. Disease recurrence is common and may manifest solely as elevated tumor markers in the absence of clinical findings or positive morphological imaging. We present the case of a 56-year-old woman diagnosed with MTC in 2011, treated with total thyroidectomy and adjuvant therapy. In 2021, a locoregional recurrence was detected, requiring left-sided neck dissection. During follow-up in 2025, elevated tumor markers were identified despite negative findings on computed tomography (CT). Consequently, an 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/CT was performed, revealing disease recurrence with multiple lesions suggestive of bone metastases. This case underscores the value of 18F-FDG PET/CT in the follow-up and detection of MTC recurrence.
No takes yet. Share an insight, caveat, or question.
Albenda et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: